Related Experiment Video

Updated: May 23, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
09:47

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates

Published on: May 10, 2022

The ubiquitin-proteasomal system is critical for multiple myeloma: implications in drug discovery

Biyin Cao1, Xinliang Mao

  • 1Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, The First Affiliated Hospital, Soochow University Suzhou, China.

American Journal of Blood Research
|March 21, 2012
PubMed

Insights

Bortezomib effectively targets proteasomes, crucial for protein degradation, showing significant promise in treating multiple myeloma. This review explores the ubiquitin-proteasomal system

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Proteasomes are key protease complexes in protein degradation.
  • Bortezomib, a proteasome inhibitor, induces apoptosis in various cancer cells.
  • Multiple myeloma exhibits high sensitivity and responsiveness to bortezomib treatment.

Purpose of the Study:

  • To review recent advancements in ubiquitin-proteasomal system (UPS) components.
  • To analyze the role of the UPS in multiple myeloma pathophysiology.
  • To discuss the implications of UPS research in drug discovery for myeloma.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of studies on proteasome inhibitors and the UPS.
  • Examination of bortezomib's mechanism of action and clinical efficacy.

Main Results:

  • The ubiquitin-proteasomal system is critical for multiple myeloma.
  • Bortezomib's efficacy in multiple myeloma is well-established.
  • Understanding UPS components offers new avenues for drug development.

Conclusions:

  • The UPS is a vital therapeutic target in multiple myeloma.
  • Targeting the UPS, particularly with inhibitors like bortezomib, is effective.
  • Further research into UPS components can lead to novel myeloma therapies.
Keywords:
Ubiquitin-proteasomal systembortezomibdeubiquitinasesdrug discoverymultiple myeloma

More Related Videos

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...